HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Brian E Marron Selected Research

5- (4- butoxy- 3- chlorophenyl)- N- ((2- morpholinopyridin- 3- yl)methyl)nicotinamide

9/2010A-887826 is a structurally novel, potent and voltage-dependent Na(v)1.8 sodium channel blocker that attenuates neuropathic tactile allodynia in rats.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Brian E Marron Research Topics

Disease

4Pain (Aches)
01/2016 - 02/2008
4Neuralgia (Stump Neuralgia)
11/2010 - 02/2008
1Seizures (Absence Seizure)
04/2021
1Hyperalgesia
09/2010
1Chronic Pain
02/2008

Drug/Important Bio-Agent (IBA)

4Sodium Channels (Sodium Channel)IBA
08/2014 - 02/2008
2Voltage-Gated Sodium ChannelsIBA
01/2016 - 02/2008
2Biological ProductsIBA
11/2010 - 02/2008
2Analgesics (Analgesic Drugs)IBA
11/2010 - 02/2008
2Sodium Channel BlockersIBA
09/2010 - 06/2008
1OxadiazolesIBA
04/2021
1Pharmaceutical PreparationsIBA
08/2014
1PyrazinesIBA
11/2010
15- (4- butoxy- 3- chlorophenyl)- N- ((2- morpholinopyridin- 3- yl)methyl)nicotinamideIBA
09/2010
1furanIBA
06/2008
1Mexiletine (Mexitil)FDA LinkGeneric
06/2008
1PiperazineIBA
06/2008
1Lamotrigine (Lamictal)FDA LinkGeneric
06/2008
1Antisense OligonucleotidesIBA
02/2008
1Tetrodotoxin (Tetradotoxin)IBA
02/2008

Therapy/Procedure

2Oral Administration
11/2010 - 09/2010
1Therapeutics
08/2014
1Analgesia
02/2008